Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Jun
7
2022
Alcohol Suppliers Hit with ADA Website Accessibility Lawsuits McDermott Will & Emery
Feb
9
2015
Out-of-Market Divestiture Required to Resolve Competitive Concerns McDermott Will & Emery
Aug
26
2022
Departments Issue Final Rule Implementing Certain No Surprises Act Provisions McDermott Will & Emery
Aug
21
2019
Third Circuit Upholds Decision Blocking Trump Administration’s Birth Control Rules McDermott Will & Emery
Aug
30
2019
FDA Regulatory Check-Up: CBD and Dietary Supplements McDermott Will & Emery
Sep
27
2019
Equivalent Disclosure Used To Satisfy Written Description Requirement McDermott Will & Emery
Oct
4
2019
McDermottPlus Check-up: October 4, 2019 McDermott Will & Emery
Dec
29
2022
Welcome (but Last Minute) Relief for Prescription Drug Reporting Originally Due December 27 McDermott Will & Emery
Jan
12
2016
Federal Trade Commission Policy Statement on Deceptively Formatted Advertisements McDermott Will & Emery
Dec
20
2019
EPA Approves Use of 10 Pesticide Products on Hemp McDermott Will & Emery
Apr
7
2023
CMS Issues Medicare Drug Price Negotiation Initial Guidance, First Inflation Rebate List McDermott Will & Emery
Mar
30
2016
Reformulated OxyContin Patents Invalid McDermott Will & Emery
Mar
7
2020
Mississippi Supreme Court Rejects ‘Passage of Title’ DTC Theory McDermott Will & Emery
Jun
23
2023
MCDERMOTTPLUS CHECK-UP: JUNE 23, 2023 McDermott Will & Emery
Aug
4
2023
Holy Pulmonary Hypertension, Batman: Method of Treatment Not Constrained by Safety and Efficacy McDermott Will & Emery
Aug
22
2023
Top Takeaways | 2023 Physician Practice Management & ASC Symposium | Maximizing Managed Practice Value & Operations McDermott Will & Emery
Aug
17
2016
FDA Issues Final Rule on Food Ingredients that May Be Generally Recognized as Safe (GRAS) McDermott Will & Emery
Nov
17
2016
FDA Hosts Public Meeting on Off-Label Communications McDermott Will & Emery
Dec
29
2016
Texas Court of Appeals Hands Down Instructive Administrative Law Opinion McDermott Will & Emery
Dec
19
2023
The Tax Implications of Purchasing Craft Producers in the First Half of 2024 McDermott Will & Emery
Feb
7
2017
Final Rule Modernizes Substance Use Disorder Patient Record Confidentiality Regulations McDermott Will & Emery
Feb
16
2024
This Week in 340B: February 7 – 13, 2024 McDermott Will & Emery
Feb
22
2024
Mixed Beverage Definition Gaining Traction in Indiana McDermott Will & Emery
Dec
21
2020
An Early Holiday Present for Generics? Legislation Requiring Greater Disclosure by Brands Passes the Senate McDermott Will & Emery
Jan
11
2021
HHS Advisory Opinion Concludes Manufacturers Must Deliver 340 B Drugs to Contract Pharmacies McDermott Will & Emery
Apr
25
2024
CMS Advises Preparatory Steps for Anticipated PrEP Coverage Transition to Medicare Part B McDermott Will & Emery
May
6
2024
Healthcare Preview for the Week of: May 6, 2024 [Podcast] McDermott Will & Emery
Jun
26
2017
RICO Madness: Marijuana Operations Face RICO Challenges in Federal Courts McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins